https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accounts-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-bonuses-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-liabilities-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-payroll-taxes-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-rent-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-salaries-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accrued-vacation-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accumulated-amortization-deferred-finance-costs https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/accumulated-depreciation https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/amended-reports-10-k https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/amended-reports-10-q https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/amortization https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/amortization-of-financing-costs https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/aoci https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/area-of-real-estate-property https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/asset-impairment-charges https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/available-for-sale-amortized-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/available-for-sale-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/available-for-sale-debt-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/available-for-sale-noncurrent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/available-for-sale-securities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/bank-overdrafts https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/basic-shares https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/buybacks-form-sc-to-i https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/buybacks-payments-for-repurchase-of-warrants https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-expenditures https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-lease-obligations https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-lease-obligations-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-lease-obligations-incurred https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/capital-leases-future-minimum-payments-due-in-two-and-three-years https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash-and-equivalents https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash-and-restricted-cash https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cash-flow-breakdown https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/commercial-paper https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/common-stock-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/comprehensive-income https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/contribution-of-property https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/current-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/current-liabilities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-interest-rate-effective-percentage-rate-range-maximum https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-interest-rate-effective-percentage-rate-range-minimum https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-issued https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-maturing-after-year-five https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-maturing-in-year-five https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-maturing-in-year-four https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-maturing-in-year-three https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-periodic-payment-principal https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/debt-repaid https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-rent-credit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-rent-credit-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-charitable-contribution-carryforwards https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-liabilities-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/depreciation https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/depreciation-and-amortization https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/derivative-gain-loss-recognized-in-income-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/derivative-liabilities-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/derivative-number-of-instruments-held https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/diluted-shares https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/effective-tax-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/eps https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/eps-basic https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-transfers-into-level https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/financing-cash-flow https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/form-d-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/general-and-administrative-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/income-tax https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/income-taxes-paid https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-insurance-settlements-receivable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insider-transactions-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insider-transactions-other/purchases https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insider-transactions-other/sales https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insider-transactions-warrants https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/insurance-recoveries https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-and-debt-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-expense-lessee-assets-under-capital-lease https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-income-expense-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-paid https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/interest-paid-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/investing-cash-flow https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/investment-income-interest https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/investment-income-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/lease-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/leasehold-improvements-gross https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/line-of-credit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/line-of-credit-facility-capacity-available-for-trade-purchases https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/line-of-credit-facility-commitment-fee-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/line-of-credit-facility-decrease-repayments https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/lines-of-credit-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/loans-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/loans-payable-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/long-term-line-of-credit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/long-term-loans-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/long-term-notes-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/marketable-securities-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-cash-from https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-change-in-cash https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-income https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/noncash-or-part-noncash-divestiture-amount-of-consideration-received https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/notes-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/notes-payable-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/number-of-operating-segments https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-cash-flow https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-expenses https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-income https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-liability https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-liability-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-2 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/operating-leases-rent-expense-net https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-current-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-general-and-administrative-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-income https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-liabilities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-noncash-income-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-noncurrent-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-noncurrent-liabilities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-nonoperating-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-nonoperating-income https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/paid-in-capital-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/paid-in-kind-interest https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/payments-for-operating-activities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/payments-for-restructuring https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/payments-to-acquire-equipment-on-lease https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/pension-and-other-postretirement-benefit-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/pension-expense-reversal-of-expense-noncash https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/preferred-shares-facts https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/prepaid-expense-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/prepaid-expense-other-noncurrent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/prepaid-rent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-convertible-debt https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-other-debt https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-repayments-of-lines-of-credit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-repayments-of-other-long-term-debt https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-stock-plans https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/profit-loss https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/property-plant-equipment https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/public-float https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/repayments-of-lines-of-credit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/repayments-of-notes-payable https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/research-and-development https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/research-and-development-arrangement-contract-to-perform-for-others-costs-incurred-gross https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restructuring-charges https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restructuring-costs https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restructuring-reserve https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/restructuring-reserve-current https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/retained-earnings https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/revenue https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-comment-letters-corresp https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-comment-letters-upload https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-10-k https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-10-q https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-10ksb https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-10qsb https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-25-nse https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-8-a12b https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-8-a12g https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-8-k https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-ars https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-certnas https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-def-14a https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-defa14a https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-no-act https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-pre-14a https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-prer14a https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-regdex https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-sb-2 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/sec-filings-sc-14f1 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-effect https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-fwp https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/shareholders-equity https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/shares-authorized https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/shares-issued https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/shares-issued-shares-espps https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/short-term-lease-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/short-term-lease-payments https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-based-compensation https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-employee-benefit-plan https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-restricted-stock-award-forfeited https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-shares-stock-splits https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-option-plan-expense https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-expirations-in-period https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-vested-in-period-fair-value-1 https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stock-split-ratio https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/stockholders-equity-note-stock-split-conversion-ratio https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-deductions-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/total-assets https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/total-liabilities https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/variable-lease-cost https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/invivo-therapeutics-holdings-corp/weighted-average-number-of-share-outstanding-basic-and-diluted